BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 21342275)

  • 21. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
    Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
    BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.
    Gillenwater AM; Vigneswaran N; Fatani H; Saintigny P; El-Naggar AK
    Head Neck; 2014 Nov; 36(11):1662-8. PubMed ID: 24115154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative verrucous leukoplakia of the gingiva.
    Fettig A; Pogrel MA; Silverman S; Bramanti TE; Da Costa M; Regezi JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):723-30. PubMed ID: 11113818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exophytic oral verrucous hyperplasia: a new entity.
    Patil S; Warnakulasuriya S; Raj T; Sanketh DS; Rao RS
    J Investig Clin Dent; 2016 Nov; 7(4):417-423. PubMed ID: 26075572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
    Sun Z; Gong Y; Huang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral medicine case book 37. Proliferative verrucous leukoplakia.
    Padayachee S; Peck MT; Dreyer WP; Allie A; Afrogheh A
    SADJ; 2012 Mar; 67(2):78-80. PubMed ID: 23189896
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinicopathologic correlations of oral premalignant lesions and squamous cell carcinomas.
    Kootman J; El-Mofty SK
    J Mo Dent Assoc (1980); 1982; 62(6):33-5. PubMed ID: 6961228
    [No Abstract]   [Full Text] [Related]  

  • 29. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports].
    Colella G; De Luca F; Lanza A; Tartaro GP
    Minerva Stomatol; 1995 Jun; 44(6):291-300. PubMed ID: 7476784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions.
    Lee JJ; Hung HC; Cheng SJ; Chiang CP; Liu BY; Yu CH; Jeng JH; Chang HH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):217-25. PubMed ID: 17560138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukoplakia: still a gallimaufry or is progress being made?--A review.
    Suarez P; Batsakis JG; el-Naggar AK
    Adv Anat Pathol; 1998 May; 5(3):137-55. PubMed ID: 9868520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leukoplakia and erythroplakia--two orale precursor lesions].
    Grajewski S; Groneberg D
    Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a possible anatomical subsite-mediated effect of tobacco in oral potentially malignant disorders and carcinoma.
    Pentenero M; Giaretti W; Navone R; Rostan I; Gassino L; Broccoletti R; Arduino PG; Malacarne D; Gandolfo S
    J Oral Pathol Med; 2011 Mar; 40(3):214-7. PubMed ID: 21198867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferative verrucous leukoplakia: an aggressive form of oral leukoplakia.
    Shopper TP; Brannon RB; Stalker WH
    J Dent Hyg; 2004; 78(3):7. PubMed ID: 16197744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal studies in oral leukoplakias.
    Bánóczy J; Sugár L
    J Oral Pathol; 1972; 1(6):265-72. PubMed ID: 4217821
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
    Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
    Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.
    Radhakrishnan R
    Indian J Dent Res; 2011; 22(3):365-6. PubMed ID: 22048571
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinicopathologic analysis of verrucous hyperplasia, verrucous carcinoma and squamous cell carcinoma as part of the clinicopathologic spectrum of oral proliferative verrucous leukoplakia: A literature review and analysis.
    Akrish S; Eskander-Hashoul L; Rachmiel A; Ben-Izhak O
    Pathol Res Pract; 2019 Dec; 215(12):152670. PubMed ID: 31630872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.